Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab – study protocol.

Saved in:
Bibliographic Details
Title: Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab – study protocol.
Authors: Janssen, J. C.1,2 (AUTHOR), van Dijk, B.1 (AUTHOR), de Joode, K.1 (AUTHOR), Aarts, M. J. B.3 (AUTHOR), van den Berkmortel, F. W. P. J.4 (AUTHOR), Blank, C. U.5,6 (AUTHOR), Boers-Sonderen, M. J.7 (AUTHOR), van den Eertwegh, A. J. M.8 (AUTHOR), de Groot, J. W. B.9 (AUTHOR), Jalving, M.10 (AUTHOR), de Jonge, M. J. A.1 (AUTHOR), Joosse, A.1 (AUTHOR), Kapiteijn, E.6 (AUTHOR), Kamphuis-Huismans, A. M.11 (AUTHOR), Naipal, K. A. T.1 (AUTHOR), Piersma, D.12 (AUTHOR), Rikhof, B.13 (AUTHOR), Westgeest, H. M.14 (AUTHOR), Vreugdenhil, G.15 (AUTHOR), Oomen-de Hoop, E.1 (AUTHOR)
Source: BMC Cancer. 5/23/2024, Vol. 24 Issue 1, p1-7. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 177625751
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab – study protocol.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Janssen%2C+J%2E+C%2E%22">Janssen, J. C.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+Dijk%2C+B%2E%22">van Dijk, B.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Joode%2C+K%2E%22">de Joode, K.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aarts%2C+M%2E+J%2E+B%2E%22">Aarts, M. J. B.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+den+Berkmortel%2C+F%2E+W%2E+P%2E+J%2E%22">van den Berkmortel, F. W. P. J.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Blank%2C+C%2E+U%2E%22">Blank, C. U.</searchLink><relatesTo>5,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Boers-Sonderen%2C+M%2E+J%2E%22">Boers-Sonderen, M. J.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+den+Eertwegh%2C+A%2E+J%2E+M%2E%22">van den Eertwegh, A. J. M.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Groot%2C+J%2E+W%2E+B%2E%22">de Groot, J. W. B.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jalving%2C+M%2E%22">Jalving, M.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Jonge%2C+M%2E+J%2E+A%2E%22">de Jonge, M. J. A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Joosse%2C+A%2E%22">Joosse, A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kapiteijn%2C+E%2E%22">Kapiteijn, E.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kamphuis-Huismans%2C+A%2E+M%2E%22">Kamphuis-Huismans, A. M.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Naipal%2C+K%2E+A%2E+T%2E%22">Naipal, K. A. T.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Piersma%2C+D%2E%22">Piersma, D.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rikhof%2C+B%2E%22">Rikhof, B.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Westgeest%2C+H%2E+M%2E%22">Westgeest, H. M.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vreugdenhil%2C+G%2E%22">Vreugdenhil, G.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Oomen-de+Hoop%2C+E%2E%22">Oomen-de Hoop, E.</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22BMC+Cancer%22">BMC Cancer</searchLink>. 5/23/2024, Vol. 24 Issue 1, p1-7. 7p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=177625751
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12885-024-12336-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 1
    Titles:
      – TitleFull: Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab – study protocol.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Janssen, J. C.
      – PersonEntity:
          Name:
            NameFull: van Dijk, B.
      – PersonEntity:
          Name:
            NameFull: de Joode, K.
      – PersonEntity:
          Name:
            NameFull: Aarts, M. J. B.
      – PersonEntity:
          Name:
            NameFull: van den Berkmortel, F. W. P. J.
      – PersonEntity:
          Name:
            NameFull: Blank, C. U.
      – PersonEntity:
          Name:
            NameFull: Boers-Sonderen, M. J.
      – PersonEntity:
          Name:
            NameFull: van den Eertwegh, A. J. M.
      – PersonEntity:
          Name:
            NameFull: de Groot, J. W. B.
      – PersonEntity:
          Name:
            NameFull: Jalving, M.
      – PersonEntity:
          Name:
            NameFull: de Jonge, M. J. A.
      – PersonEntity:
          Name:
            NameFull: Joosse, A.
      – PersonEntity:
          Name:
            NameFull: Kapiteijn, E.
      – PersonEntity:
          Name:
            NameFull: Kamphuis-Huismans, A. M.
      – PersonEntity:
          Name:
            NameFull: Naipal, K. A. T.
      – PersonEntity:
          Name:
            NameFull: Piersma, D.
      – PersonEntity:
          Name:
            NameFull: Rikhof, B.
      – PersonEntity:
          Name:
            NameFull: Westgeest, H. M.
      – PersonEntity:
          Name:
            NameFull: Vreugdenhil, G.
      – PersonEntity:
          Name:
            NameFull: Oomen-de Hoop, E.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 05
              Text: 5/23/2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 14712407
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC Cancer
              Type: main
ResultId 1